Sickle Cell Treatment Shows Promise in Phase 1 Clinical Trial
The Dana-Farber/Boston Children’s Cancer and Blood Disorders Center have seen promising early results in a clinical trial to treat sickle cell disease. The first patient to undergo treatment has not received a blood transfusion in nine months, after receiving monthly blood transfusions for most of his life (1). Sickle Cell Disease Sickle cell disease is [Read More]